AstraZeneca – Express Pharma

AstraZeneca appoints Ram Mudaliar as India Lead of its Clinical Data and Insights division

US FDA grants priority review to Daiichi Sankyo and AstraZeneca’s sBLA of Enhertu

AstraZeneca welcomes US government’s announcement to purchase additional 500,000 doses of Evusheld

University of Oxford study supports use of Vaxzevria as third-dose booster against Omicron

Serum waives AstraZeneca shot indemnity for refugee programme

WHO grants Emergency Use Listing for Novavax and SII’s COVID-19 vaccine

Evusheld long-acting antibody combination retains neutralising activity against Omicron variant in independent FDA study

Pfizer set to oust AstraZeneca as top supplier of COVID-19 shots to poor nations

Two-dose vaccines induce lower antibodies against Omicron, says study

US FDA grants EUA to AstraZeneca’s Evusheld in US for pre-exposure prophylaxis of COVID-19